ArticleOncology2023

The Glasgow Prognostic Score Predicts Survival in Patients with Advanced Non-Small Cell Lung Cancer Harboring Sensitive Epidermal Growth Factor Receptor Mutations Who Are Treated with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors.

Yuki Akazawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.